Emicizumab for the Treatment of Acquired Hemophilia_A: Lessons Learned from 4 Very Different Cases

被引:13
|
作者
Knoebl, Paul [1 ]
Sperr, Wolfgang R. [2 ]
Schellongowski, Peter [3 ]
Staudinger, Thomas [3 ]
Jilma-Stohlawetz, Petra [4 ]
Quehenberger, Peter [4 ]
Koder, Silvia [1 ]
Ay, Cihan [5 ]
Gleixner, Karoline V. [6 ]
机构
[1] Med Univ Vienna, Dept Med 1, Div Hematol & Hemostasis, Vienna, Austria
[2] Med Univ Vienna, Dept Internal Med 1, Div Hematol & Hemostaseol, Vienna, Austria
[3] Med Univ Vienna, Dept Med 1, Intens Care Unit, Vienna, Austria
[4] Med Univ Vienna, Dept Lab Med, Vienna, Austria
[5] Med Univ Vienna, Vienna, Austria
[6] Med Univ Vienna, Dept Internal Med 1, Div Hematol & Hemostasis, Vienna, Austria
关键词
D O I
10.1182/blood-2018-99-116973
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
2476
引用
收藏
页数:2
相关论文
共 50 条
  • [11] Emicizumab for the treatment of acquired hemophilia A: Retrospective review of a single-institution experience
    Chen, Evan C.
    Gibson, William
    Temoczko, Paula
    Connell, Nathan T.
    Handin, Robert
    Parnes, Aric D.
    HAEMOPHILIA, 2023, 29 (01) : 84 - 89
  • [12] Emicizumab in acquired hemophilia A: pros and cons of a new approach to the prevention and treatment of bleeding
    Pasca, Samantha
    Zanon, Ezio
    Mannucci, Pier
    Peyvandi, Flora
    BLOOD TRANSFUSION, 2023, 21 (06)
  • [13] Acquired hemophilia A and emicizumab for the treatment of bleeding: two case report and a literature review
    Launois, Amelie
    Martin-Toutain, Isabelle
    Devaux, Floriane
    Lambert, Juliette
    Longval, Thomas
    Merabet, Fatiha
    Jaidi, Rym
    Le Dore, Sophie
    Ferre, Emmanuelle
    Rousselot, Philippe
    De Raucourt, Emmanuelle
    Flaujac, Claire
    ANNALES DE BIOLOGIE CLINIQUE, 2024, 82 (03) : 294 - 307
  • [14] EMICIZUMAB TREATMENT IN PATIENT WITH ACQUIRED HEMOPHILIA CAN BE A RELAY TO BYPASSING AGENTS: A CASE REPORT
    Toutain, I. Martin
    Launois, A.
    Lambert, J.
    Longval, T.
    Merabet, F.
    Jaidi, R.
    LeDore, S.
    Ferre, E.
    De Raucourt, E.
    Flaujac, C.
    HAEMOPHILIA, 2023, 29 : 98 - 98
  • [15] LESSONS TO BE LEARNED FROM DIFFICULT CASES
    ALBOM, MJ
    JOURNAL OF DERMATOLOGIC SURGERY AND ONCOLOGY, 1984, 10 (10): : 791 - 791
  • [16] From psychophysics to the world••• data acquired, lessons learned
    Moskowitz, H
    FOOD QUALITY AND PREFERENCE, 2004, 15 (7-8) : 633 - 644
  • [17] EMICIZUMAB AS A TREATMENT FOR ACQUIRED HEMOPHILIA AFTER VARIOUS LINE'S FAILURE AS WELL AS FOR A SERIOUS HEMORRAGIAL COMPLICATION
    Carrasco Exposito, M.
    Vilalta Seto, N.
    Mateo Arranz, J.
    HAEMOPHILIA, 2023, 29 : 55 - 56
  • [18] Treatment of acquired hemophilia in the elderly. Study of 10 cases
    Antonio Rodriguez-Garcia, Jose
    Martinez-Robles, Violeta
    Perez-Gutierrez, Belen
    MEDICINA CLINICA, 2019, 152 (01): : 34 - 36
  • [19] Management of surgery in persons with hemophilia A receiving emicizumab prophylaxis: data from a national hemophilia treatment center
    Cohen, Omri
    Levy-Mendelovich, Sarina
    Budnik, Ivan
    Ludan, Noa
    Lyskov, Shani Kassia
    Livnat, Tami
    Avishai, Einat
    Efros, Orly
    Lubetsky, Aharon
    Lalezari, Shadan
    Misgav, Mudi
    Brutman-Barazani, Tami
    Kenet, Gili
    Barg, Assaf A.
    RESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASIS, 2023, 7 (06)
  • [20] MANAGEMENT OF PATIENTS WITH HEMOPHILIA A ON EMICIZUMAB PROPHYLACTIC TREATMENT: RECOMMENDATION FROM RUSSIAN EXPERTS
    Andreeva, T. A.
    Zharkov, P. A.
    Zozulya, N., I
    Zorenko, V. Yu
    Konstantinova, V. N.
    Lebedev, V. V.
    Mamaev, A. N.
    Markova, I., V
    Petrov, V. Yu
    Polyanskaya, T. Yu
    Schiller, E. E.
    GEMATOLOGIYA I TRANSFUZIOLOGIYA, 2022, 67 (02): : 267 - 280